-
Age between 18 and 75 years old;
-
BMI between 18.5 kg/m² and 35.0 kg/m²;
-
Receiving a stable dose of metformin treatment for at least 60 days;
-
HbA1c between 7.5% and 11.0%; fasting blood glucose ≤ 15.0 mmol/L;
-
Patients currently have poor glycemic control with metformin and have never used semaglutide.
Patient benefits: a total of 5100 yuan. The sponsor provides trial medications and metformin [Products: THDB0225 injection, semaglutide injection (Novo Nordisk®)].
All products have been marketed!!!
11 hospital visits and 2 phone visits. Transportation fee 200 yuan/visit, blood collection subsidy 200 or 300 yuan/visit, total subsidy 5100 yuan.
Contact: Dr. Yang 19710210807 (same number on WeChat)
